Albrioza

sodium phenylbutyrate; ursodoxicoltaurine · Amylyx Pharmaceuticals EMEA B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albrioza, covering 2024-02-01 to 2024-02-01. Get the full timeline:

Most recent: EMA Refused: Albrioza (sodium phenylbutyrate;ursodoxicoltaurine) — Amylyx Pharmaceuticals EMEA B.V.